Prof. Man-Fung Yuen


Professor Yuen, MBBS, MD, PhD, DSc, is Chair Professor of The University of Hong Kong and Li Shu Fan Medical Foundation Professor in Medicine and the Chief of the Division of Gastroenterology and Hepatology at Queen Mary Hospital, Hong Kong. He obtained his first bachelor’s degree in medicine in 1992. He further pursued academic excellence by obtaining three doctoral degrees, including a Doctor of Medicine with Sir Patrick Manson Gold Medal in 2001, a Doctor of Philosophy in 2005, and a Doctor of Science in 2017. Professor Yuen’s research interests include prevention, natural history, serology, virology and treatment of chronic hepatitis B and C and hepatocellular carcinoma.   

 He is one of the top internationally renowned researchers in the field of hepatitis B disease. He has now published more than 570 papers in world-renowned medical journals, including the New England Journal of Medicine, Lancet, Nature Medicine, Lancet Infectious Diseases and Lancet Oncology. According to the Expertscape academic online platform, which analyses 25,130 publications during the period between 2013 and 2023, he is ranked the top 1 researcher under the category of “hepatitis B” ( According to another academic performance metric, the AD Scientific Index 2024 (, he is ranked the 16th world scientist in field of Gastroenterology and the 1,178th out of 148,666 in all subjects of Medical and Health Sciences. Up till now, he has delivered more than 330 lectures all over the world.  

 As a world-class clinician-scientist, Professor Yuen now leads most international trials examining new drugs, including antiviral and immunomodulatory agents, for treating chronic hepatitis B. He is also actively performing cutting-edge research on novel markers for hepatitis B infection and occult hepatitis B infection. With all these international academic and professional achievements, Professor Yuen is an invited member serving as a key opinion leader for several international coalition committees, including the International Coalition to Eliminate HBV (ICE-HEP) and Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) on hepatitis B disease.